Summary: Donation of CCP, Blood Components and HCT/Ps, Including Information on COVID-19 Vaccines or Treatment with CCP or Monoclonals (updated 04/14/21)
This section contains information on questionnaires used to screen prospective donors and help ensure the safety of the donation process as well as the product being donated. AABB has played a leadership role in the development of model questionnaires for blood collection facilities as well as for facilities involved in the collection of hematopoietic progenitor cells (HPCs).
UK’s Revised Donor Eligibility Criteria Take Effect
June 15, 2021
ADVANCE Study Recruiting MSM Interested in Blood Donation
May 18, 2021
UK to Introduce Individualized Risk Assessment in June
May 11, 2021